Fairvalue-Calculator Fairvalue-Calculator

Hubei Huaqiang High-Tech Co (688151) Fair Value & Analysis

Healthcare · CN · Market cap 5.7B CNY

Price¥15.99
Fair Value¥7.74
Upside-51.6%
Quality95/100
Evidence: High Range ¥7.61 – ¥7.87

Analysis

Hubei Huaqiang High-Tech Co (688151) currently trades at ¥15.99, while our model-based Fair Value estimate is ¥7.74 — implying the stock looks roughly 51.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Hubei Huaqiang High-Tech Co., Ltd. research, develops, produces, and sells special protective equipment, pharmaceutical packaging, and medical devices in China. The company operates as a chemical defense military enterprise in special protection. It offers personal protective equipment, such as anti-virus clothing and boot covers, and gas masks; collective protective equipment, comprising cooperative supporting and demobilized troops products, pre-filters, air inlet components, particle filters, filter absorbers, poison filter ventilation devices, and collective protection system equipment; and chemical defense equipment for national civil air defense projects, such as civil air defense filters and doors, and impregnated carbon. It also provides pharmaceutical packaging and medical devices, such as medicinal butyl rubber stoppers, multi-layer co-extruded films, aluminum-plastic covers, medical masks, and medical protective clothing; conventional and film-coated rubber stoppers, and …

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.